ENO3 and cancer: Of the 10 proteins, the preceding text showed that some studies identified RRM2, PLOD2, MKI67, MCM5, and CKD1 promoted cancer progression and FBP1, FBP2, ENO3, GPD1, and ASS1 inhibited cancer progression, which was consistent with our results (Figure S1).